Яз
Country: Israel
Language: Russian
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
DROSPIRENONE 3 MG; ETHINYLESTRADIOL 0.02 MG
Available from:
BAYER ISRAEL LTD
ATC code:
G03AA12
Pharmaceutical form:
FILM COATED TABLETS
Administration route:
PER OS
Manufactured by:
BAYER WEIMAR GMBH UND CO.KG, GERMANY
Therapeutic group:
DROSPIRENONE AND ESTROGEN
Therapeutic indications:
- Oral contraception. - Treatment of moderate acne vulgaris in women who seek oral contraception. - Treatment of symptoms of premenstrual dysphoric disorder (PMDD ) in women who have chosen oral contraceptives as their method of birth control. The efficacy of Yaz for PMDD was not assessed beyond 3 cycles. Yaz has not been evaluated for treatment of PMS ( premenstrual syndrome ).
Authorization date:
2009-07-01
